-
1Academic Journal
Authors: Wi, Ji Hun a, b, 1, Lee, Hyelim a, c, 1, Park, Ji Min d, 2, Heo, Yeonju d, Jo, Seongman d, e, Lee, Jeehee a, f, Kim, Yeseul a, j, Jung, Cheulhee b, Kim, Nam-Jung c, g, Song, Gyu Yong e, Kim, Pilho d, h, ⁎, Kim, Hyejin d, h, i, ⁎, Lee, Sanghee a, g, ⁎⁎
Source: In Biomedicine & Pharmacotherapy May 2025 186
-
2Academic Journal
Authors: Jeon, Min Jae, Lee, Hyelim, Jo, Seongman, Kang, Miso, Jeong, Jeong Hyun, Jeong, So Hyeon, Lee, Joo-Youn, Song, Gyu Yong, Choo, Hyunah, Lee, Sanghee, Kim, Hyejin
Source: In European Journal of Medicinal Chemistry 5 December 2023 261
-
3Academic Journal
Authors: Oh, Jong-Seok, Choi, Jungwan, Suh, Jae-Hak, Choi, Jihyun, Lee, Lacksang, Kim, Changwoo, Park, Hyungjin, Jo, Seongman, Lee, Seungyun, Hwang, Kwangcheol, Liu, Hyoyol, Hong, Ki-Don, Sim, Dong-Joon, Lee, Jang-Soo, Lee, Eui-Jae, Kwon, Yang-Hae, Lee, Dae-Yeol, Ko, Ki-Won, Kim, Jong-Min, Song, Inho, Reynaud, Pascal, Tan, Hao, Tao, Jun, Goff, Jeremy
Source: In Fusion Engineering and Design October 2015 98-99:1127-1130
-
4Academic Journal
Authors: Jung, Hee Ra, Jo, Seongman, Jeon, Min Jae, Lee, Hyelim, Chu, Yeonjeong, Lee, Jeehee, Kim, Eunha, Song, Gyu Yong, Jung, Cheulhee, Kim, Hyejin, Lee, Sanghee
Source: Biomedicines; Jan2022, Vol. 10 Issue 1, p33-33, 1p
Subject Terms: TYPE I interferons, IMMUNOTHERAPY, ANTINEOPLASTIC agents, CANCER treatment, IMMUNE response